| Bioactivity | Tenecteplase (TNK-tPA) is a modified tissue plasminogen activator. Tenecteplase (TNK-tPA) can be used for acute ischaemic stroke diseases research[1]. |
| Name | Tenecteplase |
| CAS | 191588-94-0 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kvistad CE, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022 Jun;21(6):511-519. |